search
Back to results

Stop Tip-toeing Around Toe-walking

Primary Purpose

Spastic Cerebral Palsy (sCP)

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Static stability measurement
Dynamic stability measurement
Sponsored by
University Children's Hospital Basel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Spastic Cerebral Palsy (sCP) focused on measuring tip-toeing, toe-walking, gait cycle, heel-strike, Static stability, Dynamic stability, Virtual Reality, Cerebral Palsy (CP)

Eligibility Criteria

7 Years - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria for TD children:

  • between the age of 7 and 18 years
  • who are typically developing
  • able to stand and walk alone without using assistance or assistive devices
  • able to place their feet flat on the force platforms
  • with enough German language skills to follow the instructions

Inclusion Criteria for sCP children:

  • between the age of 7 and 18 years
  • with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS)
  • being able to stand and walk alone without assistance or assistive devices
  • able to place their feet flat on the force platforms
  • with enough German language skills to follow the instructions

Exclusion Criteria for TD children:

  • severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
  • any vestibular problems (e.g. severe motion sickness)
  • history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
  • prior experience of VR to ensure a comparable baseline between subjects

Exclusion Criteria for sCP children:

  • severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion
  • severe knee flexion gait (>45°)
  • walking capacity <50m
  • botulinum toxin type A treatment (past 6 months)
  • orthopedic surgery of upper or lower extremities (past 12 months)
  • any vestibular problems (e.g. severe motion sickness or dizziness)
  • history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation)
  • prior experience of VR as they may already be adapted to VR.

Sites / Locations

  • University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Typically Developing (TD) children

Spastic Cerebral Palsy (sCP) children

Arm Description

Static stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) who are typically developing, 3) able to stand and walk alone without using assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.

Static stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS) [98], 3) being able to stand and walk alone without assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.

Outcomes

Primary Outcome Measures

Static stability assessed by Center of Pressure (COP) shifts in anterior-posterior and mediolateral directions under each limb
COP shifts in anterior-posterior and mediolateral directions under each limb are assessed via the use of two force plates embedded in the floor (Kistler Instrumente AG, Winterthur, Switzerland, sample rate 1500 Hz) (mean value of three repetitions)
Static stability assessed by Visual Analogue Scale (VAS)
Self-perceived degree of safety during walking in the VR environment will be assessed using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")
Static stability assessed by Ratio between H-reflex and M-wave amplitude
Ratio between H-reflex and M-wave amplitude, measured through soleus muscle in affected side of hemiplegic sCP and in none-dominant side for diplegic CP and TD (recruitment curve of the H-reflex and the M-wave of the Soleus elicited by stimulating the tibial nerve while standing)
Dynamic stability assessed by COP shifts in combination with base of support trajectory
COP shifts in combination with base of support trajectory assessed via the use of four force plates embedded in the floor (mean value of three repetitions)
Dynamic stability assessed by number of muscle synergies
Number of muscle synergies assessed via the use of a sixteen-channel surface electromyography system
Dynamic stability assessed by interlimb coordination
Interlimb coordination will be calculated by using kinematic data from lower and upper extremities
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS)
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")

Secondary Outcome Measures

Dynamic stability measurement assessed by kinematic data of upper & lower extremities (joint angles in degree)
Dynamic stability measurement assessed by kinematic data of upper & lower extremities (joint angles in degree)
Dynamic stability measurement assessed by spatiotemporal parameters: walking speed (normalized to leg length) [m/(s*mm)]
Dynamic stability measurement assessed by spatiotemporal parameters: walking speed (normalized to leg length) [m/(s*mm)]
Dynamic stability measurement assessed by spatiotemporal parameters: stride width [s]
Dynamic stability measurement assessed by spatiotemporal parameters: stride width [s]
Dynamic stability measurement assessed by spatiotemporal parameters: double support time [s]
Dynamic stability measurement assessed by spatiotemporal parameters: double support time [s]
Dynamic stability measurement assessed by spatiotemporal parameters: cadence [steps/min]
Dynamic stability measurement assessed by spatiotemporal parameters: cadence [steps/min]
Dynamic stability measurement assessed by spatiotemporal parameters: step length [m]
Dynamic stability measurement assessed by spatiotemporal parameters: step length [m]

Full Information

First Posted
May 3, 2021
Last Updated
October 17, 2023
Sponsor
University Children's Hospital Basel
search

1. Study Identification

Unique Protocol Identification Number
NCT04879199
Brief Title
Stop Tip-toeing Around Toe-walking
Official Title
Stop Tip-toeing Around Toe-walking: Towards a Better Understanding and More Effective Treatment of Toe-walkers With Cerebral Palsy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
August 11, 2021 (Actual)
Primary Completion Date
September 30, 2023 (Actual)
Study Completion Date
September 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Children's Hospital Basel

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to explore the interplay among nervous-, musculoskeletal-, and psychological systems and how they impact toe-walking behavior, and vice versa. Sub-Project 1 is to analyze the feasibility of the developed virtual reality (VR) environment, in 10 TD and sCP children respectively. It is assess the effects of VR immersion on predefined static and dynamic stability parameters. Sub-Project 2: After adjustments have been made following Sub-Project 1 regarding the study procedure, technical factors or the parameters of interest etc., the optimized study procedure is implemented in Sub-Project 2 (20 to 25 TD will be included). Sub-Project 3: After adjustments have been made following Sub-Project 1 regarding the study procedure, technical factors or the parameters of interest etc., the optimized study procedure is implemented in Sub-Project3 (20 to 25 sCP will be included)
Detailed Description
The interplay between the nervous-, musculoskeletal-, and psychological systems and their impact on resulting walking patterns are poorly understood. Children that toe-walk often show poorer levels of static and dynamic stability, leading to a lower quality of life compared to typically develop-ing children (TD). Current research suggests multifactorial adaptations in central and/or peripheral nervous as well as the musculoskeletal system contribute to and result from toe-walk-ing. The purpose of this study is to explore the interplay among nervous-, musculoskeletal-, and psychological systems and how they impact toe-walking behavior, and vice versa. The effect of psychological factors (via the use of a custom-designed virtual reality environment) on static vs. dynamic stability, motor control, coordination (indirect assessment of central nervous system function) as well as reflex control (Hoffmann-reflex, H-reflex, performance of peripheral nervous system) is investigated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spastic Cerebral Palsy (sCP)
Keywords
tip-toeing, toe-walking, gait cycle, heel-strike, Static stability, Dynamic stability, Virtual Reality, Cerebral Palsy (CP)

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Cross sectional, age-matched-controlled and monocentric study with an exploratory approach.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
46 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Typically Developing (TD) children
Arm Type
Experimental
Arm Description
Static stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) who are typically developing, 3) able to stand and walk alone without using assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.
Arm Title
Spastic Cerebral Palsy (sCP) children
Arm Type
Experimental
Arm Description
Static stability and Dynamic stability measurement in children with: 1) between the age of 7 and 18 years, 2) with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS) [98], 3) being able to stand and walk alone without assistance or assistive devices, 4) able to place their feet flat on the force platforms, and 5) with enough German language skills to follow the instructions.
Intervention Type
Diagnostic Test
Intervention Name(s)
Static stability measurement
Intervention Description
The child stands barefoot on dual force platforms in two (CP: three) different conditions: barefoot and with shoes (CP: and with orthosis). Each condition is recorded three times each lasting for 30s, and 30s rest between them. Both conditions are recorded with and without wearing a headset. The order of conditions (within each Virtual Reality ("VR)-condition") is randomized. For each condition, the child rests in a comfortable position for 20s with the heels on the same level and arms hanging at their sides. Between both "VR-conditions", the child rests for 120 s.
Intervention Type
Diagnostic Test
Intervention Name(s)
Dynamic stability measurement
Intervention Description
The child walks at their normal walking speed on a 10-m walkway in two (CP: three) different conditions: barefoot and with shoes (CP: and with orthosis). For each condition, at least six error-free trials are recorded. Errors in data may occur due to hidden or lost markers during walking or software interruptions. Both conditions are recorded with and without wearing a headset. The order of conditions (within each "VR-condition") is randomized.
Primary Outcome Measure Information:
Title
Static stability assessed by Center of Pressure (COP) shifts in anterior-posterior and mediolateral directions under each limb
Description
COP shifts in anterior-posterior and mediolateral directions under each limb are assessed via the use of two force plates embedded in the floor (Kistler Instrumente AG, Winterthur, Switzerland, sample rate 1500 Hz) (mean value of three repetitions)
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Static stability assessed by Visual Analogue Scale (VAS)
Description
Self-perceived degree of safety during walking in the VR environment will be assessed using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Static stability assessed by Ratio between H-reflex and M-wave amplitude
Description
Ratio between H-reflex and M-wave amplitude, measured through soleus muscle in affected side of hemiplegic sCP and in none-dominant side for diplegic CP and TD (recruitment curve of the H-reflex and the M-wave of the Soleus elicited by stimulating the tibial nerve while standing)
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability assessed by COP shifts in combination with base of support trajectory
Description
COP shifts in combination with base of support trajectory assessed via the use of four force plates embedded in the floor (mean value of three repetitions)
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability assessed by number of muscle synergies
Description
Number of muscle synergies assessed via the use of a sixteen-channel surface electromyography system
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability assessed by interlimb coordination
Description
Interlimb coordination will be calculated by using kinematic data from lower and upper extremities
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS)
Description
Dynamic stability assessed by Self-perceived degree of safety during walking in the VR environment using a Visual Analogue Scale (VAS) ranging from 0 ("feeling completely safe") to 10 ("feeling completely unsafe")
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Secondary Outcome Measure Information:
Title
Dynamic stability measurement assessed by kinematic data of upper & lower extremities (joint angles in degree)
Description
Dynamic stability measurement assessed by kinematic data of upper & lower extremities (joint angles in degree)
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability measurement assessed by spatiotemporal parameters: walking speed (normalized to leg length) [m/(s*mm)]
Description
Dynamic stability measurement assessed by spatiotemporal parameters: walking speed (normalized to leg length) [m/(s*mm)]
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability measurement assessed by spatiotemporal parameters: stride width [s]
Description
Dynamic stability measurement assessed by spatiotemporal parameters: stride width [s]
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability measurement assessed by spatiotemporal parameters: double support time [s]
Description
Dynamic stability measurement assessed by spatiotemporal parameters: double support time [s]
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability measurement assessed by spatiotemporal parameters: cadence [steps/min]
Description
Dynamic stability measurement assessed by spatiotemporal parameters: cadence [steps/min]
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)
Title
Dynamic stability measurement assessed by spatiotemporal parameters: step length [m]
Description
Dynamic stability measurement assessed by spatiotemporal parameters: step length [m]
Time Frame
one time assessment at baseline (complete baseline assessments up to 3 hours)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria for TD children: between the age of 7 and 18 years who are typically developing able to stand and walk alone without using assistance or assistive devices able to place their feet flat on the force platforms with enough German language skills to follow the instructions Inclusion Criteria for sCP children: between the age of 7 and 18 years with the diagnosis of spastic CP or CP similar (both unilateral and bilateral), functionally classified level I or II according to the Gross Motor Function Classification System (GMFCS) being able to stand and walk alone without assistance or assistive devices able to place their feet flat on the force platforms with enough German language skills to follow the instructions Exclusion Criteria for TD children: severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion any vestibular problems (e.g. severe motion sickness) history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation) prior experience of VR to ensure a comparable baseline between subjects Exclusion Criteria for sCP children: severe visual, cognitive, or auditory impairments that would interfere with the study instructions and the VR immersion severe knee flexion gait (>45°) walking capacity <50m botulinum toxin type A treatment (past 6 months) orthopedic surgery of upper or lower extremities (past 12 months) any vestibular problems (e.g. severe motion sickness or dizziness) history of epilepsy, pace-marker or/and electrical pumps (due to possible interference with electrical stimulation) prior experience of VR as they may already be adapted to VR.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heide Elke Viehweger, Prof. Dr. med.
Organizational Affiliation
University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Children's Hospital Basel, Neuroorthopedics I Human Locomotion Research
City
Basel
ZIP/Postal Code
4056
Country
Switzerland

12. IPD Sharing Statement

Learn more about this trial

Stop Tip-toeing Around Toe-walking

We'll reach out to this number within 24 hrs